These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31562694)

  • 1. A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.
    Link KG; Stobb MT; Sorrells MG; Bortot M; Ruegg K; Manco-Johnson MJ; Di Paola JA; Sindi SS; Fogelson AL; Leiderman K; Neeves KB
    J Thromb Haemost; 2020 Feb; 18(2):306-317. PubMed ID: 31562694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computationally Driven Discovery in Coagulation.
    Link KG; Stobb MT; Monroe DM; Fogelson AL; Neeves KB; Sindi SS; Leiderman K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):79-86. PubMed ID: 33115272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.
    Shao Y; Wu W; Xu G; Wang X; Ding Q
    Blood; 2019 Nov; 134(20):1745-1754. PubMed ID: 31558466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency.
    Dhinoja S; De Maria A; Qaryoute AA; Jagadeeswaran P
    Blood Coagul Fibrinolysis; 2024 Jul; 35(5):238-247. PubMed ID: 38874909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.
    Girard TJ; Lasky NM; Grunz K; Broze GJ
    J Thromb Haemost; 2019 Jan; 17(1):149-156. PubMed ID: 30451376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and phenotypic correlation in haemophilia A.
    Beltrán-Miranda CP; Khan A; Jaloma-Cruz AR; Laffan MA
    Haemophilia; 2005 Jul; 11(4):326-34. PubMed ID: 16011583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
    Mansouritorghabeh H; Shirdel A
    J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fab.
    Brophy DF; Martin EJ; Mohammed BM; Barrett JC; Kuhn JG; Nolte ME; Wiinberg B; Holmberg HL; Lund J; Salbo R; Waters EK
    Haemophilia; 2017 Nov; 23(6):941-947. PubMed ID: 28750471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of coagulation-associated processes on factor VIII immunogenicity in a mouse model of severe hemophilia A.
    Gangadharan B; Delignat S; Ollivier V; Gupta N; Mackman N; Kaveri SV; Lacroix-Desmazes S
    J Thromb Haemost; 2014 Dec; 12(12):2065-9. PubMed ID: 25267332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
    Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
    Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets significantly modify procoagulant activities in haemophilia A.
    Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
    Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prophylactic factor VIII in severe haemophilia A.
    Gissel M; Whelihan MF; Ferris LA; Mann KG; Rivard GE; Brummel-Ziedins KE
    Haemophilia; 2012 Mar; 18(2):193-9. PubMed ID: 21899664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models.
    Onasoga-Jarvis AA; Leiderman K; Fogelson AL; Wang M; Manco-Johnson MJ; Di Paola JA; Neeves KB
    PLoS One; 2013; 8(11):e78732. PubMed ID: 24236042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A; Hoffman M; Ehrenforth S
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.